-
301
Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme
Published 2022-06-01“…Introduction Inflammatory bowel disease (IBD) involves an abnormal immune response to healthy gut bacteria. …”
Get full text
Article -
302
Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
Published 2022-06-01“…Introduction Inflammatory bowel diseases (IBD), encompassing Crohn’s disease and ulcerative colitis, are chronic, inflammatory diseases of the gastrointestinal tract. …”
Get full text
Article -
303
-
304
Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study
Published 2024-06-01“…Background Timely diagnosis and treatment of inflammatory bowel disease (IBD) may improve clinical outcomes.Objective Examine associations between time to diagnosis, patterns of prior healthcare use, and clinical outcomes in IBD.Design Using the Clinical Practice Research Datalink we identified incident cases of Crohn’s disease (CD) and ulcerative colitis (UC), diagnosed between January 2003 and May 2016, with a first primary care gastrointestinal consultation during the 3-year period prior to IBD diagnosis. …”
Get full text
Article -
305
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)
Published 2025-01-01“…Introduction Crohn’s disease (CD) is a chronic, immune-mediated inflammatory bowel disease (IBD), presenting with symptoms of abdominal pain and bleeding from the gastrointestinal tract. …”
Get full text
Article -
306
-
307
The First Saint Petersburg Regional Inflammatory Bowel Diseases Registry on the Basis of the Regional Health Information System: Principles of Functioning, Testing Results, Plan of Development
Published 2023-11-01Subjects: “…inflammatory bowel diseases…”
Get full text
Article -
308
Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink
Published 2025-01-01“…It included adults newly diagnosed with inflammatory bowel disease and established on 5-aminosalicylic acid (5-ASA) treatment between 1 January 2007 and 31 December 2019. …”
Get full text
Article -
309
The role of gut microbiota in disease management: Ayurvedic perspectives on metabolic diseases and health
Published 2025-02-01Subjects: Get full text
Article -
310
Remission: does it already exist in chronic rhinosinusitis with nasal polyposis?
Published 2023-07-01Subjects: Get full text
Article -
311
Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
Published 2025-03-01Subjects: Get full text
Article -
312
Unreliable information and fear: Barriers to vaccination among IBD patients in China
Published 2025-12-01Subjects: Get full text
Article -
313
Prednisolone pharmacokinetics in dogs with protein‐losing enteropathy
Published 2025-01-01Subjects: Get full text
Article -
314
Relapsing Polychondritis and Artiritis in a Patient with Ulcerative Colitis: A Case Report
Published 2024-07-01Subjects: “…inflammatory bowel disease…”
Get full text
Article -
315
Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population
Published 2009-01-01“…Inflammatory bowel diseases (IBDs) comprising Crohn disease (CD) and ulcerative colitis (UC) are chronic inflammatory conditions with polygenic susceptibility. …”
Get full text
Article -
316
VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy.
Published 2025-02-01“…Inflammatory bowel disease (IBD) is a chronic and potentially life-threatening inflammatory disease of gastroenteric tissue characterized by episodes of intestinal inflammation, but the underlying mechanisms remain elusive. …”
Get full text
Article -
317
Therapeutic Potential of <i>Cajanus cajan</i> (L.) <i>Millsp</i>. Leaf Extract in Modulating Gut Microbiota and Immune Response for the Treatment of Inflammatory Bowel Disease
Published 2025-01-01“…<b>Background/Objectives:</b> Inflammatory bowel disease (IBD) is a persistent inflammatory condition affecting the gastrointestinal tract, distinguished by the impairment of the intestinal epithelial barrier, dysregulation of the gut microbiota, and abnormal immune responses. …”
Get full text
Article -
318
Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review
Published 2025-02-01Subjects: Get full text
Article -
319
Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective
Published 2025-01-01Subjects: Get full text
Article -
320
Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis
Published 2025-01-01Subjects: Get full text
Article